Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10520708 | 0.83 | ALDH1A1 (0.37) | ALDH1A1CYP2D6 | |
| SCHEMBL7501926 | 0.81 | — | — | |
| SCHEMBL1352445 | 0.72 | GABRR1 (0.32) | ALDH1A1CYP2D6 | |
| SCHEMBL9510919 | 0.69 | ALDH1A1 (0.35) | ALDH1A1CYP2D6 | |
| SCHEMBL440679 | 0.67 | ALDH1A1 (0.33) | ALDH1A1CYP2D6 | |
| SCHEMBL3833786 | 0.67 | — | — | |
| SCHEMBL643574 | 0.67 | CYP2D6 (0.41) | ALDH1A1CYP2D6 | |
| SCHEMBL6036749 | 0.67 | — | — | |
| SCHEMBL18727628 | 0.65 | — | — | |
| SCHEMBL6155261 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638631-A | Preparation method of key intermediate of agoraphobia | 安徽皓元药业有限公司 | 2025-03-18 | — | — | CN | claimed |
| WO-2023245857-A1 | CAPSAICIN-DERIVED PHOTOSENSITIZER, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州大学 | 2023-12-28 | — | — | WO | claimed |
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2021-05-13 | — | — | US | claimed |
| CN-110582506-A | Novel antimicrobial products | 林肯大学 | 2019-12-17 | — | — | CN | claimed |
| WO-2018162922-A1 | NEW ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LINCOLN (GB) | 2018-09-13 | — | — | WO | claimed |
| US-7345165-B2 | Method for preparing water-soluble free amine chitosan | JAE WOON NAH (KR) | 2008-03-18 | — | — | US | claimed |
| US-20040260077-A1 | Method for preparaing water-soluble free amine chitosan | JEONG, TUK RAI (KR) | 2004-12-23 | — | — | US | claimed |
| WO-2003035700-A1 | METHOD FOR PREPARING WATER-SOLUBLE FREE AMINE CHITOSAN | NAH JAE WOON (KR) | 2003-05-01 | — | — | WO | claimed |
| US-20260068886-A1 | COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL | OERTH BIO LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260008757-A1 | N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES | BASF SE (DE) | 2026-01-08 | — | — | US | disclosed |
| EP-4615855-A2 | NEW ANTIBACTERIAL PRODUCTS | University of Liverpool (GB) | 2025-09-17 | — | — | EP | disclosed |
| EP-4580405-A1 | COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL | Oerth Bio LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| CN-120152959-A | N- (3- (aminomethyl) -phenyl) -5- (4-phenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-amine derivatives and similar compounds as pesticides | 巴斯夫欧洲公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250163122-A1 | COMPOSITIONS AND METHODS FOR TREATING AIRWAY MUCUS DYSFUNCTION | UNIVERSITAET ULM (DE) | 2025-05-22 | — | — | US | disclosed |
| US-5707936-A | PESTICIDES, FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-01-13 | — | — | US | disclosed |
| CN-1161687-A | Phenylacetic acid alkyl esters | BASF AG (DE) | 1997-10-08 | — | — | CN | disclosed |
| US-5565490-A | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-15 | — | — | US | disclosed |
| US-5534653-A | FUNGICIDES, PESTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-09 | — | — | US | disclosed |
| US-5438070-A | Agricultural fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-01 | — | — | US | disclosed |
| US-5284851-A | Controlling insects, arachnids and nematodes | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | DBI, MRPL21, NRDC | ALDH1A1 1816/4885CYP2D6 1525/4885 |
| US-20260008757-A1 | N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES | HCN1, HCN3, HTR3C | ALDH1A1 1430/4885CYP2D6 1208/4885 |
| US-20260068886-A1 | COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL | CRBN, STUB1, CUL1 | ALDH1A1 3713/4885CYP2D6 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.